{"id":349,"date":"2020-05-11T05:42:23","date_gmt":"2020-05-11T05:42:23","guid":{"rendered":"http:\/\/icdlabs.in\/immune-internal\/?page_id=349"},"modified":"2024-06-21T08:01:57","modified_gmt":"2024-06-21T08:01:57","slug":"investors-media","status":"publish","type":"page","link":"https:\/\/icdlabs.in\/immune-internal\/investors-media\/","title":{"rendered":"Investors & Media"},"content":{"rendered":"
\n\n
\n
\n

investors<\/h1>\n <\/div>\n <\/section>\n<\/div>\n\n
\n\n\n
\n
\n
\n
<\/div>\n <\/div>\n
\n
\n
\n

Immuneel is championing a momentous change<\/strong>\u2014one that is human, medical, technological and economic. Join us.<\/strong><\/h3>\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n

A bold initiative to disrupt the landscape of cancer treatment in India, Immuneel is a privately-owned Indian clinical stage<\/span> startup company established in 2018, and seed-funded through angel investments and institutional capital.<\/p>\n

A first mover in India, Immuneel is pioneering the business and care delivery models which will transform the way cell and gene therapies are developed and manufactured while alleviating the suffering of an under-served population.<\/p> <\/div>\n

\n
\n

With an inspired leadership team and a wide sweep of capabilities being built, Immuneel has garnered support from leading investors across hospitals, corporates and institutions on its journey towards scale, reliability and speed.<\/p> \n Please contact\u00a0 investors@immuneel.com<\/a><\/strong>\u00a0for any queries related to investor relations. <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/section><\/div>\n\n

\n\n\n
\n
\n
\n press releases <\/div>\n
\n
\n
Download our latest press release<\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/section>\n\n\n\n\n
\n
\n
\n
\n \n
\n
\n Xth July 2024 <\/div>\n
<\/div>\n
\n Immuneel Therapeutics Secures Strategic Investment from Taiba Healthcare to Accelerate Growth <\/div>\n
\n <\/div>\n
\n \n <\/span>\n Read more<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n 13th December, 2022 <\/div>\n
<\/div>\n
\n Immuneel Therapeutics Presents Early data from India for Varnimcabtagene autoleucel (IMAGINE, Phase 2) at ASH Annual Meeting 2022, USA. <\/div>\n
\n <\/div>\n
\n \n <\/span>\n Read more<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n 21st June, 2022 <\/div>\n
<\/div>\n
\n Biotech start-up Immuneel Therapeutics announces India\u2019s first Phase II patient trials for CAR-T cancer therapies alongside a USD 15 million Series A financing <\/div>\n
\n <\/div>\n
\n \n <\/span>\n Read more<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n 18th January, 2021 <\/div>\n
<\/div>\n
\n Immuneel Announces the Inauguration of India\u2019s first Integrated Cell Therapy Development and Manufacturing Facility <\/div>\n
\n <\/div>\n
\n \n <\/span>\n Read more<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n 13th October, 2020 <\/div>\n
<\/div>\n
\n Immuneel Therapeutics, Hospital Cl\u00ednic de Barcelona & Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer Announce a Strategic collaboration & a License Agreement. <\/div>\n
\n <\/div>\n
\n \n <\/span>\n Read more<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n <\/div>\n <\/div>\n<\/section><\/div>\n\n
\n\n\n
\n
\n
\n media <\/div>\n
\n
\n

Immuneel story has the attention and interest of the business press and technology writers<\/strong><\/h3>\n
Read or watch what the press says about us
Please contact\u00a0business.communications@immuneel.com\u00a0for any queries related to media.<\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/section>\n\n\n\n\n
\n
\n
\n
\n \n
\n
\n Immuneel honoured with \u2018CGCS Pioneer Award\u2019 at the 5th International Cell & Gene Therapy China Summit & Exhibition 2024. <\/div>\n
<\/div>\n
\n CGCS is the industry\u2019s largest networking platform in Asia, bringing large pharma, innovative biotech, and academia together focussing on CGT. <\/div>\n
\n CGCS 2024 <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Narayana Health City Advances Cancer Care with Landmark CAR T-Cell Therapy Success <\/div>\n
<\/div>\n
\n Narayana Health City, Bangalore recently held a press conference to celebrate a remarkable victory against cancer, highlighting the institution\u2019s strides in … <\/div>\n
\n Healthcare Executive <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Immuneel presents exciting research work with 2 abstract(1306 & 1307) poster presentations at American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting 2024, Baltimore, USA. <\/div>\n
<\/div>\n
\n <\/div>\n
\n American Society of Gene & Cell Therapy 2024 <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Advancements in Cell and Gene Therapies: A Glimpse into the Future of Cancer Treatment with CAR-T cell immunotherapy <\/div>\n
<\/div>\n
\n CAR-T cell therapy is evidence of the amazing advancements in medical research in the worldwide battle against cancer. <\/div>\n
\n ET Health <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Reimagining pharma and healthcare for India@100. Industry Report featuring Immuneel. <\/div>\n
<\/div>\n
\n With the evolving global innovation landscape and country\u2019s ambition for 2047, the next frontier for India is to focus on transformative innovation. <\/div>\n
\n EY <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Immuneel presents exciting primary endpoint data & results from the IMAGINE study with 9 scientific abstracts at the 65th American Society of Hematology, Annual Meeting, San Diego, USA. <\/div>\n
<\/div>\n
\n <\/div>\n
\n American Society of Hematology 2023 <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n
\n \n
\n
\n \"\"\n <\/div>\n
\n
\n Dr. Arun Anand talks to Dr. Bruce Levine on future of cancer treatment and access in the cell therapy space globally. <\/div>\n
\n Immuneel Podcast <\/div>\n
\n \n <\/span>\n See Video<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n \"\"\n <\/div>\n
\n
\n Dr Arun Anand and Dr Bruce speak with Express Pharma on cutting edge cell & gene therapy <\/div>\n
\n Express Pharma <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Immuneel won the ‘Innovation in Cell and Gene Therapy’ award and Dr Arun Anand our Board Director & COO, was honoured with ‘BioPharma Leader of the Year’ award, at BioPharma Honours 2023 <\/div>\n
<\/div>\n
\n Biopharma Hounours award is aimed at honouring individuals\/organizations for their innovation & excellence in Biopharma Industry <\/div>\n
\n BioPharma Honours 2023 <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Immuneel Therapeutics paediatric subset data from IMAGINE study in India presented at SIOP 2023, Ottawa, Canada & won best poster award <\/div>\n
<\/div>\n
\n <\/div>\n
\n International Society of Paediatric Oncology 2023 <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n \"\"\n <\/div>\n
\n
\n Dr Arun Anand & Prachi Dubey talk to India Today in Health Wealth podcast about fascinating world of immunotherapy <\/div>\n
\n India Today <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n The Endpoints 11: The biotech startups making the biggest bets with the most exciting science in 2023. <\/div>\n
<\/div>\n
\n Some of the most provocative cell therapy work is happening halfway around the globe from Kendall Square, on the eighth floor of a hospital in Bengaluru, India. <\/div>\n
\n Endpoints 11 <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Immuneel honoured with \u2018The Most Promising Cell & Gene Therapy Startup in APAC\u2019 at the Asia Pacific Cell & Gene Therapy Excellence Awards 2023 <\/div>\n
<\/div>\n
\n Asia Pacific CGT Excellence Awards 2023 seeks to give recognition to exceptional Cell & Gene Therapy Pioneers, Researchers, Innovators & Manufacturers that f… <\/div>\n
\n IMAPAC <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Cancer and a bespoke therapy: Immuneel Therapeutics COO Dr Arun Anand weighs in <\/div>\n
<\/div>\n
\n In terms of sheer wizardry, the T-cell therapy technically deserves the prize. The therapy technically is so efficient that the T cells remain constantly vig… <\/div>\n
\n Money Control <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Siddhartha Mukherjee\u2019s start-up to file trial data for cancer therapy <\/div>\n
<\/div>\n
\n Immuneel Therapeutics, co-founded by Indian-born oncologist Siddhartha Mukherjee, is likely to submit safety and efficacy data from clinical trials of its br… <\/div>\n
\n Hindustan Times <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n
\n \n
\n
\n \"\"\n <\/div>\n
\n
\n Dr. Arun Anand presents at the Plenary session on \u2018Global Expansion of CAR T \u2013 Cell Therapy \u2013 India\u2019 <\/div>\n
\n Cellicon Valley 2023 <\/div>\n
\n \n <\/span>\n See Video<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Immuneel Therapeutics presents updated & exciting results for Varnimcabtagene Autoleucel (IMN-003A) from the IMAGINE study at EHA Annual Meeting 2023, Frankfurt, Germany <\/div>\n
<\/div>\n
\n <\/div>\n
\n European Haematology Association 2023 <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Immuneel Therapeutics Presents early correlative science data from IMAGINE study in India at ISCT 2023, Paris, France <\/div>\n
<\/div>\n
\n <\/div>\n
\n International Society for Cell & Gene Therapy 2023 <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n
\n \n
\n
\n \"\"\n <\/div>\n
\n
\n Dr. Arun Anand sharing insights on The COO Collective by ServiceNow and Forbes India. <\/div>\n
\n Forbes India <\/div>\n
\n \n <\/span>\n See Video<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Immuneel COO On Benchmarking The Firm\u2019s CAR-T Against Mature, Global Data Sets <\/div>\n
<\/div>\n
\n Immuneel\u2019s COO, Dr Arun Anand, talks to Scrip about how things are shaping for the Indian start-up\u2019s autologous CD19 directed CAR-T cell therapy and the \u2018jou… <\/div>\n
\n Scrip <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n
\n \n
\n
\n \"\"\n <\/div>\n
\n
\n Dr. Arun Anand sharing insights with EY on the side-lines of BioAsia 2023 about developing a market for CAR-T therapy in India. <\/div>\n
\n EY <\/div>\n
\n \n <\/span>\n See Video<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n \"\"\n <\/div>\n
\n
\n Big data set to transform drug R&D to enable scalable, affordable therapies – Panel discussion at BioAsia 2023 <\/div>\n
\n ET Healthworld <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n World Cancer Day 2023: A look at the top treatment breakthroughs in 2022 <\/div>\n
<\/div>\n
\n From new ways of conducting radiation therapies and vaccines to bone marrow transplants, this year shed a ray of hope in the oncology sphere. <\/div>\n
\n CNBCTV18 <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Providing affordable cancer treatment in India paramount: Physician <\/div>\n
<\/div>\n
\n Renowned cancer physician and author Siddhartha Mukherjee on Tuesday said one of the very important goals for him and his team is to make Chimeric Antigen Re… <\/div>\n
\n The Hindu <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Siddhartha Mukherjee’s start-up to file trial data for cancer therapy <\/div>\n
<\/div>\n
\n The move aims to make the advanced CAR-T cell therapy for cancers commercially available in India. <\/div>\n
\n Hindustan Times (East UP) <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n
\n \n
\n
\n \"\"\n <\/div>\n
\n
\n This World: Could a new cell therapy method bring a cure for cancer? <\/div>\n
\n WION TV <\/div>\n
\n \n <\/span>\n See Video<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n
\n \n
\n
\n \"\"\n <\/div>\n
\n
\n Global data on the efficacy of CAR T-cell therapy for cancer looks very good\u2019: Dr Siddhartha Mukherjee <\/div>\n
\n The Indian Express <\/div>\n
\n \n <\/span>\n See Video<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Is an Indian cure for blood cancer in sight? <\/div>\n
<\/div>\n
\n How interim results of CAR (Chimeric Antigen Receptor)-T therapy from Bengaluru start-up Immuneel lend hope for blood cancer patients in India. <\/div>\n
\n India Today <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n India\u2019s first Phase 2 multi-centre CAR-T cell therapy study gives promising results <\/div>\n
<\/div>\n
\n Immuneel Therapeutics presents early data from India for Varnimcabtagene autoleucel at ASH Annual Meeting 2022, New Orleans, USA <\/div>\n
\n BioSpectrum <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n
\n \n
\n
\n \"\"\n <\/div>\n
\n
\n Dr. Arun Anand speaking at the Summit, \u201cBiotech Future: Cell & Gene Therapy\u201d session. <\/div>\n
\n Bengaluru Tech Summit 2022 <\/div>\n
\n \n <\/span>\n See Video<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n
\n \n
\n
\n \"\"\n <\/div>\n
\n
\n Talks by Dr. Bala S. Manian and Dr. Bruce Levine on Cell & Gene Therapy. <\/div>\n
\n Celltalk 2021 Webinar <\/div>\n
\n \n <\/span>\n See Video<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n CAR T-cell therapy roll-out in low-income and middle-income countries <\/div>\n
<\/div>\n
\n For those who can endure the adverse events, chimeric antigen receptor (CAR) T-cell therapy holds enormous promise. Axicabtagene ciloleucel was approved by t… <\/div>\n
\n The Lancet <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Cancer CAR T therapy: What are the benefits and stakes? <\/div>\n
<\/div>\n
\n The last decade has been termed the immunotherapy decade in the oncology-immunology sphere \u2013 thanks to the rapid and successful research and development pipe… <\/div>\n
\n Express Pharma <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Kiran Mazumdar-Shaw on her career: \u2018I call myself an accidental entrepreneur\u2019 <\/div>\n
<\/div>\n
\n From a 25-year-old seeking finances for a small start-up to a billionaire businesswoman, Kiran Mazumdar-Shaw has come a long way. That small start-up in Indi… <\/div>\n
\n Chemical & Engineering News <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n India could be instrumental in lowering price of CAR T-cell therapy <\/div>\n
<\/div>\n
\n India could play a key role in driving down the exorbitant cost of emerging cell and gene therapies, with a combination of comparatively cheap labor and effi… <\/div>\n
\n BioWorld <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Our investment in Immuneel Therapeutics <\/div>\n
<\/div>\n
\n Our India Ventures team today announced an investment in Immuneel Therapeutics, a venture focused on creating access to CAR-T and other cellular immunotherap… <\/div>\n
\n Eightroads <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Biogen investment in Immuneel: Bringing CAR-T therapy to India <\/div>\n
<\/div>\n
\n With nearly two million new cases and a million deaths each year in India, the war against cancer is amongst the most pressing crises in the country. <\/div>\n
\n Global Regulatory & Consumer Insights <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Cut-price CAR-T cell therapies top India\u2019s biotech agenda <\/div>\n
<\/div>\n
\n Indian startups plan affordable CAR-T therapies\u2014first for domestic use, then for the global market. <\/div>\n
\n Nature Biotechnology <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n From beer to bispecifics and beyond <\/div>\n
<\/div>\n
\n India\u2019s biotech scene is buzzing, with over 600 companies and 2,800 startups which collectively contributed approximately US$12 billion to the country\u2019s econ… <\/div>\n
\n Asian Scientist Magazine <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Immuneel\u2019s radical approach to fight cancer <\/div>\n
<\/div>\n
\n Biotech veteran Kiran Mazumdar-Shaw, oncologist Siddhartha Mukherjee, and Boston VC Kush Parmar team up to found Immuneel to bring cell therapy to cancer pat… <\/div>\n
\n The Ken <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n
\n \n
\n
\n \"\"\n <\/div>\n
\n
\n Cancer: Can Cell-Therapy reverse medicine’s battle? Dr. Siddhartha Mukherjee talks to Barkha Dutt <\/div>\n
\n MOJO Story <\/div>\n
\n \n <\/span>\n See Video<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n
\n \n
\n
\n \"\"\n <\/div>\n
\n
\n Off The Cuff with Dr. Siddhartha Mukherjee <\/div>\n
\n The Print <\/div>\n
\n \n <\/span>\n See Video<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Kiran Mazumdar Shaw of Biocon and oncologist Siddhartha Mukherjee bring CAR T-cell therapy to cancer patients in India <\/div>\n
<\/div>\n
\n Biocon chairperson Kiran Mazumdar Shaw, Indian-American oncologist and author Dr Siddhartha Mukherjee and Kush Parmar, managing partner at 5AM Ventures, are … <\/div>\n
\n CNBC TV18 <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Indian cancer patients may get access to CAR T-cell therapy in 8 months, says Dr Siddhartha Mukherjee <\/div>\n
<\/div>\n
\n Indian-American oncologist and Pulitzer prize-winning author Dr Siddhartha Mukherjee has joined hands with Biocon Chairperson Kiran Mazumdar Shaw to bring in… <\/div>\n
\n CNBC TV18 <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n
\n \n
\n
\n \"\"\n <\/div>\n
\n
\n Indian cancer patients may get access to car t-cell therapy in 8 months,says dr siddhartha mukherjee <\/div>\n
\n CNBC TV18 <\/div>\n
\n \n <\/span>\n See Video<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n
\n \n
\n
\n Bringing CAR T to India <\/div>\n
<\/div>\n
\n A company formed this year in Bangalore by Kiran Mazumdar-Shaw, Kush Parmar and Siddhartha Mukherjee plans to bring a CAR T therapy to cancer patients in Ind… <\/div>\n
\n BioCentury <\/div>\n
\n \n <\/span>\n Read full story<\/span>\n <\/span>\n <\/div>\n <\/div>\n <\/a>\n <\/div>\n <\/div>\n <\/div>\n<\/section><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-349","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/icdlabs.in\/immune-internal\/wp-json\/wp\/v2\/pages\/349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/icdlabs.in\/immune-internal\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/icdlabs.in\/immune-internal\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/icdlabs.in\/immune-internal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/icdlabs.in\/immune-internal\/wp-json\/wp\/v2\/comments?post=349"}],"version-history":[{"count":5,"href":"https:\/\/icdlabs.in\/immune-internal\/wp-json\/wp\/v2\/pages\/349\/revisions"}],"predecessor-version":[{"id":1683,"href":"https:\/\/icdlabs.in\/immune-internal\/wp-json\/wp\/v2\/pages\/349\/revisions\/1683"}],"wp:attachment":[{"href":"https:\/\/icdlabs.in\/immune-internal\/wp-json\/wp\/v2\/media?parent=349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}